CELC
Celcuity Inc.
NASDAQ · Healthcare · Biotechnology · US
$57.12
+0.95%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
1772.0%
Return on equity
-27.3%
Return on assets
-28.1%
Return on invested capital
0.00x
Asset turnover
-$191.7M
Cash from operations
$15
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026